VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 5865 · 119th Congress

Thalidomide Survivors Compensation Act of 2025

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.

No cosponsors.

This bill establishes a program to compensate individuals injured by exposure to thalidomide. (Thalidomide is a medication previously used to treat nausea in pregnant women until the 1960s when it was discovered thalidomide causes severe, life-threatening birth defects.

What it does: CRS summary · Introduced in House · Oct 28, 2025

Thalidomide Survivors Compensation Act of 2025

This bill establishes a program to compensate individuals injured by exposure to thalidomide. (Thalidomide is a medication previously used to treat nausea in pregnant women until the 1960s when it was discovered thalidomide causes severe, life-threatening birth defects. Thalidomide is still used to treat multiple myeloma and leprosy, with federal restrictions to prevent use during pregnancy.)

Specifically, individuals seeking compensation may submit a petition to the Department of Health and Human Services (HHS) by May 31, 2034, with documentation from a health professional of an injury caused by exposure to thalidomide. HHS must provide $150,000 to individuals showing such injury, as determined by an expert panel. Eligible individuals must have been a U.S. citizen or permanent resident at the time of exposure and at the time the petition was submitted.

HHS may pay individuals compensated under the program additional compensation for ongoing medical or other needs as funds allow after HHS' annual review of the program, as required by the bill.

Compensation provided under the bill may not be considered when calculating income or assets under any federal program designed to provide assistance exclusively to low-income individuals (i.e., means-tested programs), including certain programs and funds specified in the bill. Compensation under the program is also excluded from gross income for federal tax purposes.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Thalidomide Survivors Compensation Act of 2025

Latest action (Oct 28, 2025): Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Policy area: Health · Origin: House · Introduced: Oct 28, 2025

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.